Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : STEM -- StemCells, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: HandsOn who wrote (275)	7/15/1999 7:22:00 PM
From: Jon Koplik	Read Replies (1) \| Respond to of 805

Start at cnbc.com I assume. Jon. eom.

To: HandsOn who wrote (275)	7/15/1999 8:48:00 PM
From: Jon Koplik	Read Replies (1) \| Respond to of 805

Thoughts on how big this news is. The important thing to me is -- what is the market cap. of CTII, and how much could one reasonably "impute" into the value of the company from today's news ? When Entremed first came out with their BIG news (actually, the second time they came out with the news -- the first time it was reported on CNN, so everyone ignored it; the second time it was in the New York Times, so the stock immediately went from around $15 to $80 or so), I took a look at it (ENMD), saw that the market cap. had run up to around $600 million, and thought : " I think a potential cure for cancer is certainly worth $600 million." Now, with CTII, all one has to hope for is that any piece of news causes people to think that the discovery is potentially worth $25 million (today's closing total value of (the whole company) CTII). Jon.